ITM Power: Operational Gains Meet Order Book Deceleration as Whitehall Decides
Published on 07/03/2026 at 14:23 | Redaktion boerse-global.de
ITM Power's shares are caught in a tug-of-war between improving financials and a cooling order intake. At 1.47 euros, the stock has bounced 13 percent over the past week from recent lows, but remains 43 percent below the May peak of 2.58 euros. With a 30-day annualised volatility of 113 percent, the market is pricing in a binary outcome that hinges as much on a UK government subsidy decision as on the company's ability to sustain order momentum.
The immediate catalyst is the fate of a state-backed funding package worth £86.5 million, announced in April. The deal includes a £40 million equity injection from Great British Energy and a planned £46.5 million capital grant from the UK energy ministry, earmarked for a new automated manufacturing line in Sheffield. The so-called Chronos electrolyser stack line would add one gigawatt of annual capacity. But the money is held up at the Competition and Markets Authority, whose Subsidy Advice Unit is still reviewing the grant. An official result has yet to land, and the company's final investment decision on the Chronos line is directly contingent on CMA clearance.
Operationally, the company has delivered its best-ever half-year revenue of £18 million, with the gross loss narrowing from £10.2 million to £6.5 million year-on-year. The order backlog swelled to £152 million, and management raised the full-year revenue forecast to a range of £40-43 million. Cash stood at £197.8 million, a modest £9.2 million decline over the past twelve months, and the government package has pushed the cash guidance for fiscal 2026 to £210-215 million. Analyst upgrades have followed, with Berenberg lifting its price target to 200 pence and Morgan Stanley turning more constructive.
Should investors sell immediately? Or is it worth buying ITM Power?
Yet beneath these headline improvements, a more worrying trend is emerging. The book-to-bill ratio, a key indicator of future revenue, has fallen from 5.5 at the end of last year to around 4. Management remained non-committal on the earnings call about whether the trend will reverse. If the ratio continues to slide, the current growth in absolute revenue will eventually run out of runway once the existing backlog is delivered. The pre-tax loss for the full year to April 2025 widened sharply from £27.1 million to £45.4 million, underscoring a business still years away from sustainable profitability.
The bear case centres on execution risk and valuation. The trailing loss per share of £0.023 leaves the stock trading on a forward price-to-earnings ratio of nearly 187, according to some models — a multiple that leaves no room for disappointment. A break below the closely watched support at £1.75 has already confirmed technical weakness. If the order book continues to shrink, analysts point to the 200-day moving average at £1.06 as a plausible downside target.
On the bullish side, a green light from the CMA would unlock the Chronos grant, allowing ITM to finalise supply contracts for the automated line. The new specifications promise significantly lower unit costs, a point that has fuelled several recent price target hikes. The next major binary events include the UK's second Hydrogen Allocation Round, Uniper's decision on the Killingholme project, and the company's full-year results due in the third calendar quarter of 2026. Each of these could either validate the bull case or deepen the doubts.
For now, the stock is caught in a waiting game. The short-term direction likely depends more on regulatory signals from Whitehall than on operational updates. If the grant is approved and the investment decision follows, a recovery toward the 50-day moving average at £1.75 is plausible. If the CMA delays or denies, the support levels at £1.29 and £1.06 come into play. The market has already voted with its feet on the order book deceleration — the next move belongs to Whitehall.
Ad
ITM Power Stock: New Analysis - 3 July
Fresh ITM Power information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
